Restifo N P, Bacík I, Irvine K R, Yewdell J W, McCabe B J, Anderson R W, Eisenlohr L C, Rosenberg S A, Bennink J R
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
J Immunol. 1995 May 1;154(9):4414-22.
CD8+ T lymphocytes (TCD8+) play an important role in cellular immune responses. TCD8+ recognize MHC class I molecules complexed to peptides of 8 to 10 residues derived largely from cytosolic proteins. Proteins are generally thought to be fragmented in the cytoplasm and delivered to nascent class I molecules in the endoplasmic reticulum (ER) by a peptide transporter encoded by the MHC. To explore the extent to which TCD8+ induction in vivo is limited by proteolysis or peptide transport into the ER, mice were immunized with recombinant vaccinia viruses containing mini-genes encoding antigenic peptides (bypassing the need for proteolysis), or these peptides with a NH2-terminal ER insertion sequence (bypassing the requirements for both proteolysis and transport). Additionally, mice were immunized with recombinant vaccinia viruses encoding rapidly degraded fragments of proteins. We report that limitations in induction of TCD8+ responses vary among Ags: for some, full length proteins are as immunogenic as other forms tested; for others, maximal responses are induced by peptides or by peptides targeted to the ER. Most importantly, in every circumstance examined, targeting peptides to the ER never diminished, and in some cases greatly enhanced, the TCD8+ immune response and provide an important alternative strategy in the design of live viral or naked DNA vaccines for the treatment of cancer and infectious diseases.
CD8 + T淋巴细胞(TCD8 +)在细胞免疫反应中起重要作用。TCD8 +识别与主要源自胞质蛋白的8至10个残基的肽复合的MHC I类分子。一般认为蛋白质在细胞质中被切割,并通过MHC编码的肽转运体递送至内质网(ER)中的新生I类分子。为了探究体内TCD8 +诱导在多大程度上受蛋白水解或肽转运到ER中的限制,用含有编码抗原肽的小基因的重组痘苗病毒免疫小鼠(绕过蛋白水解的需要),或用具有NH2末端ER插入序列的这些肽免疫小鼠(绕过蛋白水解和转运的要求)。此外,用编码蛋白质快速降解片段的重组痘苗病毒免疫小鼠。我们报告,TCD8 +反应诱导的限制在不同抗原之间有所不同:对于一些抗原,全长蛋白与测试的其他形式一样具有免疫原性;对于其他抗原,最大反应由肽或靶向ER的肽诱导。最重要的是,在每种检查的情况下,将肽靶向ER从未减少,并且在某些情况下大大增强了TCD8 +免疫反应,并为设计用于治疗癌症和传染病的活病毒或裸DNA疫苗提供了重要的替代策略。